Camilla Sylvest
Director/Board Member en ARGENX SE .
Fortuna: 88 962 $ al 31/03/2024
Perfil
Camilla Sylvest is currently serving as the Vice Chairman at World Diabetes Foundation and as an Independent Director at Danish Crown A.
She is also an Independent Non-Executive Director at argenx SE and holds the position of EVP-Commercial Strategy & Corporate Affairs at Novo Nordisk A.
Additionally, she is the Senior Vice President & General Manager-Germany at Novo Nordisk Pharma GmbH.
In terms of education, Ms. Sylvest graduated from the University of Southern Denmark in 1998 and obtained an MBA from the Scandinavian International Management Institute in 2003.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ARGEN-X SE
0.00% | 20/02/2024 | 225 ( 0.00% ) | 88 962 $ | 31/03/2024 |
Cargos activos de Camilla Sylvest
| Empresas | Cargo | Inicio |
|---|---|---|
| NOVO NORDISK A/S | Corporate Officer/Principal | 01/01/2003 |
| ARGENX SE | Director/Board Member | 08/09/2022 |
Novo Nordisk Pharma GmbH
 Novo Nordisk Pharma GmbH Pharmaceuticals: MajorHealth Technology Novo Nordisk Pharma GmbH manufacturers and distributes pharmaceutical products. It offers pharmaceutical products for diabetes, menopause, growth hormones and blood clotting which treats chronic diseases: hemophilia, growth disorders and obesity. The company was founded in 1991 and is headquartered in Mainz, Germany. | Corporate Officer/Principal | 18/10/2011 |
Danish Crown A/S
 Danish Crown A/S Food: Meat/Fish/DairyConsumer Non-Durables Danish Crown A/S wholesales and distributes meat and meat products. It operates pig and beef slaughterhouses. The firm's products include luncheon meat and sausages to hamburgers, schnitzels, and ready-made dishes for the retail trade and large scale kitchens and restaurant industry. The company was founded in 1887 and is headquartered in Randers, Denmark | Director/Board Member | - |
| World Diabetes Foundation | Director/Board Member | - |
Formación de Camilla Sylvest.
| University of Southern Denmark | Graduate Degree |
| Scandinavian International Management Institute | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| ARGENX SE | Health Technology |
| Empresas privadas | 3 |
|---|---|
Novo Nordisk Pharma GmbH
Novo Nordisk Pharma GmbH Pharmaceuticals: MajorHealth Technology Novo Nordisk Pharma GmbH manufacturers and distributes pharmaceutical products. It offers pharmaceutical products for diabetes, menopause, growth hormones and blood clotting which treats chronic diseases: hemophilia, growth disorders and obesity. The company was founded in 1991 and is headquartered in Mainz, Germany. | Health Technology |
Danish Crown A/S
Danish Crown A/S Food: Meat/Fish/DairyConsumer Non-Durables Danish Crown A/S wholesales and distributes meat and meat products. It operates pig and beef slaughterhouses. The firm's products include luncheon meat and sausages to hamburgers, schnitzels, and ready-made dishes for the retail trade and large scale kitchens and restaurant industry. The company was founded in 1887 and is headquartered in Randers, Denmark | Consumer Non-Durables |
| World Diabetes Foundation | Miscellaneous |
- Bolsa de valores
- Insiders
- Camilla Sylvest
